AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇲🇼

METHYLDOPA in Malawi

12 products registered with PMRA 0 active, 12 expired

Brand / ProductReg. No.HolderStatusExpires
NOVADOPA 250MG TABLET
TABLET
PMPB/PL31/65expired31 Mar 2025
HYDOPA 250MG TABLET
TABLET
PMPB/PL108/33expired31 Mar 2025
HY-PO-TONE 250MG TABLET
TABLET
PMPB/PL25/13expired31 Mar 2023
M-DOPA-250 250MG TABLETS
TABLETS
PMPB/PL161/37expired30 Jun 2019
ADAPAR_250 250MG TABLET
TABLET
PMPB/PL388/51expired30 Jun 2017
METHYLDOPA 250MG TABLET
TABLET
PMPB/PL365/22expired30 Jun 2016
METHYLDOPA 250MG TABLET
TABLET
PMPB/PL173/58expired30 Jun 2014
MEDOPRESS 250MG TABLET
TABLET
PMPB/PL77/31expired30 Jun 2014
METHYLDOPA 250MG TABLET
TABLET
PMPB/PL160/12expired30 Jun 2012
METHYLDOPA 250MG FILM-COATED TABLET
FILM-COATED TABLET
PMPB/PL33/6expired30 Jun 2007
HYPOTENS 250MG TABLET
TABLET
PMPB/PL7/132expired30 Jun 2007
METHYLDOPA 250MG FILM-COATED TABLET
FILM-COATED TABLET
PMPB/PL46/1expired30 Jun 2000

METHYLDOPAPMRA Registration Details

PMRA (Malawi) has 12 registered products containing METHYLDOPA, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.

Track METHYLDOPA registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Methyldopa — Malawi (PMRA) | AfricaRegulatory